Risks and regulations Compounded drugs operate under state pharmacy board oversight, not the FDAs premarket approval process
Howard Shapiro's approach is whole-person: medical oversight + nutrition strategy + behavior support for sustainable, long-term results
Driven by: Obesity & metabolic syndrome awareness Expanded indications (NASH, PCOS, heart failure, etc.) Employer & insurer push for weight-loss coverage Global access to GLP-1 drugs could save 2.1-3.1 million lives a year
For a patient already on a statin, adding semaglutide may produce additional lipid improvements beyond what the statin alone is achieving
It is essential to have an understanding of how and when to use tamoxifen correctly for maximum benefit in treating or preventing various types of breast cancer
Wegovy, which contains the same active ingredient at a higher dose, is the approved semaglutide option specifically indicated for chronic weight management